Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canji Inc.

Division of Merck & Co. Inc.

Latest From Canji Inc.

Gene Delivery: Looking Past the Skeptics

The criticism of gene therapy has been continual and consistent. But in fact, at least some delivery systems do work. It is true, however, that not all vectors work in all diseases, and the challenge for gene delivery start-ups is figuring out which ones work where.
BioPharmaceutical Business Strategies

NewBiotics Inc.

NewBiotics Inc. is harnessing the power of the thymidylate synthase (TS) enzyme. TS, which is involved in DNA synthesis, normally is overexpressed in tumor cells, leading to resistance to chemotherapeutic agents. NewBiotics is designing prodrugs that are activated by TS inside the cell, leading to programmed cell death instead of chemoprotection.
BioPharmaceutical

Dealmaking in 1995: The Theme is Product Breadth

If 1994's $61.3 billion in health care mergers seemed to put the health care industry on the road to a world of acquisition-hungry mega-merged drug, device and service companies, 1995, with its $63.7 billion in acquisition activity, has been the year of the unexpected: both in terms of what happened and what didn't.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merck & Co. Inc.
  • Senior Management
  • M. B Ingle, PhD, Chmn. & CEO
    Kenneth M Cohen, Exec. VP & COO
    Bryan S Finkle, PhD, VP, Development & Regulatory Affairs
    Stephen M Chang, PhD, VP & CSO
    H. M Shepard, PhD, VP Research
  • Contact Info
  • Canji Inc.
    Phone: (619) 597-0177
    3030 Science Park Rd. Ste. 302
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register